Synlett 2006(15): 2476-2479  
DOI: 10.1055/s-2006-950418
LETTER
© Georg Thieme Verlag Stuttgart · New York

Highly Enantioenriched 2-Azabenzonorbornenes from 7-Azabenzonorbornadienes by Asymmetric Hydroboration-Oxidation and Tandem Deoxygenation-Rearrangement-Electrophile Trapping

David M. Hodgson*, Leonard H. Winning
Department of Chemistry, University of Oxford, Chemistry Research Laboratory, Mansfield Road, Oxford OX1 3TA, UK
Fax: +44(1865)285002; e-Mail: david.hodgson@chem.ox.ac.uk;
Further Information

Publication History

Received 1 June 2006
Publication Date:
08 September 2006 (online)

Abstract

3-exo-Substituted 2-azabenzonorbornenes are accessible from 7-azabenzonorbornadienes in good yields and high enantiomeric excess via asymmetric hydroboration-oxidation, followed by tandem deoxygenation-rearrangement-electrophile trapping and also provide access to substituted aminomethylindenes.

10

Determined by chiral HPLC analysis: Chiralcel OD column (4.6 × 250 mm); flow rate: 0.9 mL/min; eluted with 1% EtOH in heptane; t R(minor) = 24.3 min, t R(major) = 26.6 min.

16

Typical Procedure for Tandem Deoxygenation-Rearrangement-Electrophile Trapping: Xanthate (+)-3 (250 mg, 0.71 mmol) was dissolved in toluene (20 mL) and then heated to reflux. (Me3Si)3SiH (256 mg, 1.1 mmol), AIBN (58 mg, 0.36 mmol) and methyl acrylate (9.6 µL, 1.1 mmol) were dissolved in toluene (4 mL) and were added to the refluxing solution via syringe pump over 100 min. The reaction mixture was allowed to reflux for a further 30 min before being cooled to r.t. and evaporated under reduced pressure. Column chromatography [SiO2; gradient elution 5% → 20% Et2O in PE (bp 30-40 °C)] of the residue gave ester (+)-10 as a colourless oil (131 mg, 56%); R f (Et2O-PE, 1:4) 0.07; [α]D 25 81.0 (c = 1.00, CHCl3). IR (neat): 2977 (m), 1739 (s), 1695 (s), 1462 (m), 1366 (s), 1260 (m), 1170 (s), 1121 (m), 1100 (m), 1074 (m), 1000 (w), 910 (w), 839 (w), 757 (m) cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.05-7.39 (m, 4 H, aromatic CH), 4.86, 4.98 (0.25 H, 0.75 H, rotamers, CH), 3.67 (s, 3 H, OCH3), 2.92-3.04, 2.79-2.92 (m, 0.75 H, 0.25 H, rotamers CH), 2.59-2.44 (m, 2 H, CH2), 2.08-2.30 (overlapping m, 2 H, 2 × CH), 1.79-1.98 (m, 1 H, CH2), 1.71-1.79 (m, 1 H, CH2), 1.35-1.42, 1.26-1.35 [m, 10 H, C(CH3)3, CH]. 13C NMR (100 MHz, CDCl3): δ = 174 (CO), 157 (CO), 146 (quat. aromatic), 144 (quat. aromatic), 127 (aromatic CH), 126 (aromatic CH), 122, 121 (rotamers, aromatic CH), 120 (aromatic CH), 79.5 [C(CH3)3], 62.7, 61.7 (rotamers, CH), 59.8 (CH), 51.8, 51.5 (rotamers, CH3), 48.2, 47.8 (rotamers, CH), 45.3, 44.8 (rotamers, CH2), 32.5, 31.9 (rotamers, CH2), 30.5, 30.3 (rotamers, CH2), 28.5, 28.3 [rotamers, C(CH3)3]. MS (CI+): m/z (%) = 332 (100) [M + H]+, 276 (43), 232 (77), 214 (12), 200(5), 183 (4), 172 (10), 158 (15), 144 (17), 130 (11), 116 (26). HRMS: m/z calcd for C19H26NO4: 332.1865; found: 332.1866.

17

This is consistent with the observation that increasing the equivalents of the alkene leads to lower yields of 12.

21

Determined by chiral GC analysis: Chirasil Dex-CD column; flow rate: 1.0 mL/min; t R (minor, not observed in the enantioenriched product) = 540 min, t R(major) = 544 min.